Hua Medicine
Hua Medicine
huamedicine.com

Locations

Shanghai, China · Shanghai, China

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series C+

founded in

2010

Hua Medicine is an innovative drug development and commercialization company based in Shanghai, China, focusing on unmet medical needs by developing novel therapies for global patients. The company has a strong emphasis on diabetes treatment, with its core product, Huadongning® (Dorzagliatin), which enhances glucose sensitivity in Type 2 diabetes patients. Approved by the NMPA in September 2022, it can be used alone or in combination with Metformin, and is suitable for patients with varying degrees of renal impairment. Hua Medicine collaborates with Bayer for the commercialization of Huadongning® in China, aiming to benefit diabetes patients and their families. The company is committed to continuous innovation and aims to lead global diabetes medical innovation.

Something looks off?
Open jobs at Hua Medicine
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.